Journal profile · Oncology
Carcinogenesis
ISSN 0143-3334 · eISSN 1460-2180 · Oxford University Press · ENGLAND · Monthly · Founded 1980
Carcinogenesis: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.75; hybrid open access; APC about USD 4,835; median 119 days to acceptance (76 articles, last 24 months); community-reported acceptance: about 33.33%; 109 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Carcinogenesis is published by Oxford University Press and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Carcinogens and Genotoxicity Assessment, DNA Repair Mechanisms and Genomics, phytochemicals, and oxidative stress, together about 32.6% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Carcinogenesis: Integrative Cancer Research is a multi-disciplinary journal that brings together all the varied aspects of research that will ultimately lead to the prevention of cancer in man. The journal publishes papers that warrant prompt publication in the areas of Biology, Genetics and Epigenetics (including the processes of promotion, progression, signal transduction, apoptosis, genomic instability, growth factors, cell and molecular biology, mutation, DNA repair, genetics, etc.), Cancer Biomarkers and Molecular Epidemiology (including genetic predisposition to cancer, and epidemiology), Inflammation, Microenvironment and Prevention (including molecular dosimetry, chemoprevention, nutrition and cancer, etc.), and Carcinogenesis (including oncogenes and tumor suppressor genes in carcinogenesis, therapy resistance of solid tumors, cancer mouse models, apoptosis and senescence, novel therapeutic targets and cancer drugs).
Source: LetPub
Research area (LetPub): Oncology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Carcinogens and Genotoxicity AssessmentBiochemistry, Genetics and Molecular Biology15.7%
- DNA Repair MechanismsBiochemistry, Genetics and Molecular Biology10.6%
- Genomics, phytochemicals, and oxidative stressBiochemistry, Genetics and Molecular Biology6.3%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology6%
- Cancer-related Molecular PathwaysMedicine5.9%
- Glutathione Transferases and PolymorphismsBiochemistry, Genetics and Molecular Biology4.7%
- Estrogen and related hormone effectsBiochemistry, Genetics and Molecular Biology3.9%
- DNA and Nucleic Acid ChemistryBiochemistry, Genetics and Molecular Biology3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.75LetPub ·
- CiteScore 2026-06
- 6.1LetPub ·
- SJR 2026-06
- 1.02LetPub ·
- SNIP 2026-06
- 0.73LetPub ·
- h-index
- 189LetPub ·
- h-index
- 262OpenAlex ·
- i10-index
- 11,153OpenAlex ·
- 2-year mean citedness
- 2.95OpenAlex ·
- Self-citation rate
- 2.6%LetPub ·
- Share of gold OA articles
- 18.11%LetPub ·
Volume
- Articles per year
- 78LetPub ·
Articles by year OpenAlex count · 14,146 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 44 | 17 | 10 |
| 2025 | 109 | 47 | 224 |
| 2024 | 82 | 41 | 459 |
| 2023 | 95 | 43 | 979 |
| 2022 | 103 | 49 | 1,389 |
| 2021 | 123 | 61 | 2,290 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
119 daysMedian, submission to acceptance · P25–P75 90 days – 173 days
- Acceptance to online
- median 22 days (11 articles)
- Submission to online
- median 199 days
- Sample
- 76 articles with submission and acceptance dates (193 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 33.33%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,835 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Oxford University Press
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 1980
- ISSN
- 0143-3334
- Electronic ISSN
- 1460-2180
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Carcinogenesis
What CAS zone is Carcinogenesis in?
In the 2025 upgraded edition of the CAS Journal Ranking, Carcinogenesis is in Zone 3 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Carcinogenesis?
The latest impact factor listed by LetPub is 3.75; CiteScore 6.1, h-index 262.
How long does peer review take at Carcinogenesis?
Based on the dates recorded on 76 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 119 days (interquartile range 90–173 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 33.33%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Carcinogenesis?
According to LetPub and DOAJ records, Carcinogenesis is indexed in SCIE and Scopus.
Is Carcinogenesis open access, and what is the APC?
Carcinogenesis is a hybrid journal. For open-access publication: APC about USD 4,835.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .